Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$11.88 - $34.13
Next Earnings Date
Apr 24 2025
Next Earnings Date
Apr 24 2025
Latest price
Market Cap | $1.95B |
EV | $1.68B |
Shares Outstanding | 109.92M |
Beta | 0.65 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $33.14 |
P/E 2025E | - |
P/Revenue 2025E | 3.19x |
Revenue | 4.20% |
EPS | -40.70% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 9.50% |
EPS | 1.10% |
Operating Cash Flow | - |
Free Cash Flow | 27.90% |
Gross Margin 2025E | 72.55% |
Net Profit Margin 2025E | -35.95% |
ROE 2025E | -48.08% |
ROCE 2024 | -46.67% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
NovoCure Limited
NVCR
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Danziger, Asaf
Employees
1,488
Website
www.novocure.comIPO Date
2015-10-01
Headquarters
No. 4 The Forum, Second Floor, Grenville Street, Saint Helier JE2 4UF, Jersey
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved